Modern treatment of hypertrophic cardiomyopathy

• Albert A. Hagеge

Abstract

The article focuses on the treatment of adult patients with hypertrophic cardiomyopathy (HCM) of genetic origin with mutations in the genes encoding sarcomeric proteins. Syndromic HCM cases are excluded from the analysis. The author describes the current views and indications for drug therapy, septal myectomy, septal ablation and cardioverter defibrillator implantation. The questions of the proband‘s family screening as a mandatory diagnostic option are discussed.

Keywords:hypertrophic cardiomyopathy, myectomy, septal ablation

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)